Question 1

How long before I see results from the Vascular Cleanse Protocol?

Accepted Answer

Carotid plaque regression studies show measurable changes at 26 weeks of consistent use. Some inflammatory markers and fibrinogen levels may improve within 4–8 weeks. Imaging confirmation requires formal cardiovascular workup.

Question 2

Can I take the Vascular Cleanse Protocol with statins?

Accepted Answer

Yes — fibrinolytic enzymes and statins act on completely different mechanisms. Discuss with your cardiologist, as this combination may produce additive benefits.

Question 3

Why is the evening dose important in the Vascular Cleanse Protocol?

Accepted Answer

Cardiovascular events are statistically most common in the early morning (6am–12pm). Nattokinase has a plasma half-life of approximately 8 hours. Evening dosing ensures peak fibrinolytic activity during the high-risk morning window.

Question 4

Do I need to cycle the Vascular Cleanse Protocol?

Accepted Answer

Unlike hormonal compounds, fibrinolytic enzymes do not cause receptor downregulation. Long-term continuous use is appropriate. A reduced maintenance dose is used after the initial 3-month phase.

Question 5

What imaging tracks progress during the Vascular Cleanse Protocol?

Accepted Answer

Carotid intima-media thickness (CIMT) ultrasound is non-invasive and directly measures plaque burden. Coronary Artery Calcium (CAC) score via CT is the gold standard. Discuss baseline and follow-up imaging with your physician.

Question 6

Is Lumbrokinase better than Nattokinase for vascular health?

Accepted Answer

Lumbrokinase contains 6 fibrinolytic isozymes versus nattokinase's single enzyme. Clinical evidence supports its use in stroke and peripheral artery disease. It is more expensive and harder to source. For most users, nattokinase + serrapeptase is the appropriate starting point.